Skip to main content
Indietro

Pulmonary Embolism: Pathophysiology, Diagnosis, and Treatment

Guida di studio - Note intelligenti

Appunti personalizzati basati sui tuoi materiali, ampliati con definizioni chiave, esempi e contesto.

Disorders of Pulmonary Circulation

Pulmonary Embolism Overview

Pulmonary embolism (PE) is a critical disorder of pulmonary circulation characterized by the obstruction of blood flow within the pulmonary arteries. This condition can range from asymptomatic presentations to sudden death, depending on the size and location of the embolus and the patient's underlying cardiopulmonary status.

  • Definition: Mechanical obstruction of blood flow in the pulmonary arteries, most commonly due to thrombotic emboli.

  • Types of Emboli:

    • Thrombotic (most common; usually from deep vein thrombosis)

    • Fat emboli (e.g., long bone fracture)

    • Air embolism

    • Amniotic fluid embolism (e.g., ruptured membranes)

  • Clinical Range: Asymptomatic to sudden death

  • Filtering Function: Pulmonary vasculature filters venous blood, preventing particles from entering arterial circulation

  • Tolerance: Patients without significant cardiopulmonary disease can tolerate up to 1/3 occlusion of lung perfusion before hemodynamic compromise occurs

Thrombotic Embolism

Thrombotic emboli are the most common cause of PE and originate outside the pulmonary circulation, typically from the deep veins of the lower extremities.

  • Origin: Lower extremities (popliteal, femoral, iliac veins)

  • Calf thrombi: Less associated with PE

  • Upper extremity thrombi: Less common

  • Example: Saddle embolus at pulmonary artery bifurcation

Risk Factors for Thromboembolism

Risk factors for PE are classified into three main categories: venous stasis, hypercoagulable states, and vascular damage.

Risk

Examples

Venous stasis

Bed-ridden/prolonged hospitalization or nursing home, paralysis/spinal cord injury, lengthy travel (> 4 hours)

Hypercoagulable

Genetics (Factor V Leiden, prothrombin mutations, protein C and S deficiency), family history, active cancer, estrogen therapy, obesity, pregnancy, antiphospholipid syndrome

Vascular damage

Trauma, surgery (especially orthopedic), central venous catheter placement

Ventilation/Perfusion (V/Q) Mismatch in PE

PE leads to mismatches between ventilation and perfusion, resulting in hypoxemia and impaired gas exchange.

  • Low V/Q: Vasoconstricted units lose perfusion, leading to decreased surfactant production and alveolar collapse

  • Dead space ventilation: Ventilation of blocked/vasoconstricted units (high V/Q)

  • Compensation: Pulmonary arterial pressure (PAP) increases blood flow to normal units

  • Shunt: Very low V/Q, resulting in hypoxemia

Pathophysiology of Pulmonary Embolism

The pathophysiological effects of PE involve hemodynamics, gas exchange, and the work of breathing.

Category

Mechanism

Hemodynamics

↑ Pulmonary vascular resistance due to vascular obstruction and vasoconstriction (thromboxane A2, serotonin)

Gas Exchange

Hypoxemia (↓ PaO2) from perfusion of low V/Q units and decreased cardiac output; alveolar dead space from vascular obstruction and perfusion of high V/Q units

Work of Breathing

↓ Lung compliance (↓ surfactant production, edema, alveolar hemorrhage); ↑ Airway resistance (reflex bronchoconstriction); Tachypnea (stimulation of irritant receptors, response to hypoxia)

Clinical Presentation

PE presents with a variety of respiratory, hemodynamic, and hypoxemic symptoms. Evidence of deep vein thrombosis (DVT) is present in about 70% of cases.

  • Respiratory (cardinal symptoms):

    • Sudden onset dyspnea

    • Bronchoconstriction (wheezing), crackles on lung auscultation

    • Tachypnea (shallow breathing)

    • Pleuritic chest pain due to alveolar hemorrhage

    • Hemoptysis (coughing up blood)

  • Hemodynamic:

    • ↑ Pulmonary artery pressure (pulmonary hypertension)

    • ↓ Cardiac output (with large emboli or saddle embolus)

    • Near-syncope or syncope

    • Tachycardia

  • Hypoxemia:

    • V/Q mismatch

    • Low PaO2

    • Lactic acidosis

  • Evidence of DVT: Positive D-dimer (lab), swelling/redness/pain in lower extremities

Clinical Presentation: Massive Pulmonary Emboli

Massive PE is characterized by significant or absolute loss of cardiac output and presents with severe symptoms.

  • Sudden collapse/death

  • Low blood pressure (shock)

  • Loss of consciousness

  • Crushing substernal chest pain

  • Rapid, weak pulse

  • Cyanosis

  • Jugular venous congestion (JVD)

Diagnosis of Pulmonary Embolism

Diagnosis of PE involves clinical suspicion, laboratory testing, and imaging studies.

  • Clinical suspicion: Only ~20% of suspected cases are confirmed

  • If low risk: D-dimer test (high sensitivity, low specificity)

  • If high risk: Pulmonary imaging

Imaging Modalities for PE Diagnosis

  • CT Pulmonary Angiography (CTPA): First-line imaging; requires contrast medium injection (contraindicated in renal insufficiency or allergy)

  • Ventilation/Perfusion (V/Q) Scan: Uses inhaled and injected radioisotope to assess perfusion abnormalities

Treatment of Pulmonary Embolism

Treatment depends on hemodynamic stability and includes anticoagulation and, in severe cases, thrombolysis.

  • Hemodynamically stable:

    • Anticoagulation: Warfarin, Heparin (IV; initial/bridge therapy), Low Molecular Weight Heparins (Enoxaparin), Factor Xa inhibitors (Rivaroxaban, Apixaban)

  • Hemodynamically unstable (SBP < 90 mmHg):

    • Thrombolysis followed by anticoagulation

    • Alteplase (tissue plasminogen activator): degrades fibrin clot

Key Equations and Concepts

  • Alveolar Gas Equation:

  • V/Q Ratio: Describes the relationship between ventilation (V) and perfusion (Q) in the lung

Additional info: The notes have been expanded to include definitions, mechanisms, and clinical context for each topic, as well as relevant equations and tables for exam preparation.

Pearson Logo

Study Prep